ATYR PHARMA INC's ticker is LIFE and the CUSIP is 002120202. A total of 43 filers reported holding ATYR PHARMA INC in Q2 2023. The put-call ratio across all filers is 2.01 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $263,557 | -26.9% | 166,808 | 0.0% | 0.00% | – |
| Q2 2023 | $360,305 | +106.9% | 166,808 | +101.2% | 0.00% | – |
| Q1 2023 | $174,107 | -52.1% | 82,908 | -50.0% | 0.00% | – |
| Q4 2022 | $363,138 | +45.8% | 165,816 | +100.0% | 0.00% | – |
| Q3 2022 | $249,000 | +6.0% | 82,908 | 0.0% | 0.00% | – |
| Q2 2022 | $235,000 | -47.1% | 82,908 | 0.0% | 0.00% | – |
| Q1 2022 | $444,000 | +6.2% | 82,908 | +48.1% | 0.00% | – |
| Q4 2021 | $418,000 | -17.7% | 55,999 | 0.0% | 0.00% | – |
| Q3 2021 | $508,000 | +88.8% | 55,999 | +1.4% | 0.00% | – |
| Q2 2021 | $269,000 | – | 55,199 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alyeska Investment Group, L.P. | 725,984 | $3,223,000 | 0.05% |
| Marquette Asset Management, LLC | 18,848 | $84,000 | 0.03% |
| FEDERATED HERMES, INC. | 1,615,000 | $7,171,000 | 0.02% |
| VIKING GLOBAL INVESTORS LP | 587,444 | $2,608,000 | 0.01% |
| TWO SIGMA INVESTMENTS, LP | 132,123 | $587,000 | 0.00% |
| OPPENHEIMER & CO INC | 18,343 | $81,000 | 0.00% |
| Renaissance Technologies | 365,830 | $1,624,000 | 0.00% |
| TWO SIGMA ADVISERS, LP | 80,950 | $359,000 | 0.00% |
| FMR LLC | 1,402,874 | $6,229,000 | 0.00% |
| ACADIAN ASSET MANAGEMENT LLC | 67,964 | $302,000 | 0.00% |